148 related articles for article (PubMed ID: 11519354)
1. [Antiinflammatory effect of a topical corticosteroid: known brand versus generic drug].
Castanedo-Cázares JP; Quistián-Galván J; Torres-Alvarez B; Torres-Ruvalcaba A; Moncada B
Gac Med Mex; 2001; 137(4):311-4. PubMed ID: 11519354
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of the efficacy of topical corticosteroid: five locally made and one brand name creams.
Puavilai S; Krisadaphong P; Leenutaphong V; Asawanonda P; Akaraphan R; Ploysangham T; Ruangkarnchanasetr S; Noppakun N; Charuwichitratana S; Kulthanan K; Huiprasert P; Tresukosol P; Ophaswongse S
J Med Assoc Thai; 2002 Jul; 85(7):789-99. PubMed ID: 12296411
[TBL] [Abstract][Full Text] [Related]
3. A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay.
Olsen EA
Arch Dermatol; 1991 Feb; 127(2):197-201. PubMed ID: 1990984
[TBL] [Abstract][Full Text] [Related]
4. A double-blind clinical study of bufexamac and fluocinolone acetonide in dermatitis.
Mackey JP
J Ir Med Assoc; 1974 Apr; 67(8):214-6. PubMed ID: 4597141
[No Abstract] [Full Text] [Related]
5. Are generic formulations equivalent to trade name topical glucocorticoids?
Stoughton RB
Arch Dermatol; 1987 Oct; 123(10):1312-4. PubMed ID: 3662563
[TBL] [Abstract][Full Text] [Related]
6. Preliminary clinical evaluation of a new topical corticosteroid, halopredone acetate, as compared to fluocinonide.
Rampini E; Rastelli A; Divano C
Arzneimittelforschung; 1977; 27(12):2396-9. PubMed ID: 341903
[TBL] [Abstract][Full Text] [Related]
7. Fluocinonide: a new topical corticosteroid for psoriasis and other dermatoses.
Counce JH; Brass A
J La State Med Soc; 1972 Oct; 124(10):365-7. PubMed ID: 5079531
[No Abstract] [Full Text] [Related]
8. Treatment of non-inflammatory dermatoses. A double-blind comparison of 1% hydrocortisone plus 10% urea and 0.05% fluocinonide.
Khan SA
Practitioner; 1978 Aug; 221(1322):265-7. PubMed ID: 364458
[No Abstract] [Full Text] [Related]
9. [Local treatment of eczema with flupamesone. Double blind study with fluocinolone acetonide].
Rodríguez Moreno T; Rodríguez Cañas T
Rev Clin Esp; 1976 Aug; 142(3):255-60. PubMed ID: 788066
[No Abstract] [Full Text] [Related]
10. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
[TBL] [Abstract][Full Text] [Related]
11. [Clinical effectiveness of fluocinonide in several skin diseases].
Tomoka MT; Ochoa AG
Wien Med Wochenschr; 1973 Apr; 123(15):247-8. PubMed ID: 4267190
[No Abstract] [Full Text] [Related]
12. Evaluation of fluocinonide cream.
Coskey RJ; Bryan HG
Mich Med; 1973 Jan; 72(1):45-6. PubMed ID: 4684179
[No Abstract] [Full Text] [Related]
13. [Molecular basis of the action of topical glucocorticoids].
Kibler-Nockowska M
Przegl Dermatol; 1979; 66(4):421-5. PubMed ID: 386434
[No Abstract] [Full Text] [Related]
14. [Antiinflammatory treatment of hemorrhoids and anal fissures].
Seghezzi R; Ercoli A; Bordonaro L
Minerva Chir; 1968 Dec; 23(24):1296-306. PubMed ID: 5735149
[No Abstract] [Full Text] [Related]
15. [Comments on the article "Study of the anti-inflammatory effect of a topical corticosteroid].
Lifshitz A; Frati A
Gac Med Mex; 2001; 137(6):624-5. PubMed ID: 11766471
[No Abstract] [Full Text] [Related]
16. Fluocinonide cream. In a variety of dermatoses.
Jaffe MO; Alt TH
Minn Med; 1974 Dec; 57(12):953-4. PubMed ID: 4607722
[No Abstract] [Full Text] [Related]
17. [On the comparative determination of the reaction preventive effect of external corticoid drugs].
Friderich H
Arztl Forsch; 1967 Nov; 21(11):431-8. PubMed ID: 5632080
[No Abstract] [Full Text] [Related]
18. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
[TBL] [Abstract][Full Text] [Related]
19. Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching.
Margolese HC; Wolf Y; Desmarais JE; Beauclair L
Int Clin Psychopharmacol; 2010 May; 25(3):180-2. PubMed ID: 20216221
[TBL] [Abstract][Full Text] [Related]
20. [Topsyne Gras. Role of the vehicle in local corticotherapy].
Huriez
Lille Med; 1973 Nov; 18(9):1031-4. PubMed ID: 4603924
[No Abstract] [Full Text] [Related]
[Next] [New Search]
